Trials / Terminated
TerminatedNCT02080091
Observational Study to Assess the Effect of Iluvien® in DME Patients Insufficiently Responsive to Available Therapies
ILUMINATE: An Open-Label, Non-Interventional Study of the Safety and Effect of Iluvien® (Fluocinolone Acetonide 190 Micrograms Intravitreal Implant in Applicator) in Patients With Chronic Diabetic Macular Edema (DME) Insufficiently Responsive to Available Therapies
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- Alimera Sciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This observational study aims to assess the safety and effect of Iluvien® in DME patients considered insufficiently responsive to available therapies in a real life setting in Germany.
Conditions
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2015-03-01
- Completion
- 2015-04-01
- First posted
- 2014-03-06
- Last updated
- 2015-08-26
- Results posted
- 2015-08-10
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02080091. Inclusion in this directory is not an endorsement.